Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Jan 5:zwaf789.
doi: 10.1093/eurjpc/zwaf789. Online ahead of print.

Gender-Affirming Hormone Therapy and Vascular Health: Walking the Line Between Caution and Confidence

Virginie Grouthier  1   2 , Marion Camoin  1 , Sami Fawaz  3 , Pierre Mora  2   4 , Amandine Galioot  1 , Valentin Maury  3 , Romane Lebourdon  3 , Michel Montaudon  5 , Marie-Ange Renault  2 , Antoine Tabarin  1 , Thierry Couffinhal  2   3
Affiliations

Gender-Affirming Hormone Therapy and Vascular Health: Walking the Line Between Caution and Confidence

Virginie Grouthier et al. Eur J Prev Cardiol. .

Abstract

Aim: Cardiovascular (CV) risk assessment in transgender individuals remains poorly understood. Emerging data suggest a potential increase in CV risk associated with gender-affirming hormone therapy(GAHT). Conventional tools such as coronary artery calcium(CAC) scoring may underestimate risk in this young population. Advanced imaging techniques (coronary computed tomography angiography CCTA and 3-dimensional supra-aortic trunk ultrasonography SATUS) may provide more accurate evaluation, but their relevance in transgender cohorts has not yet been established. We aimed to assess early CV risk modification of GAHT using several innovative imaging techniques.

Methods: We conducted a prospective, single-center study at Bordeaux University Hospital, enrolling transgender individuals initiating or continuing GAHT. Participants undergone clinical and biological assessment and CV imaging(CAC, CCTA, SATUS) at baseline and after 18months.

Results: Thirty-four participants (17transmen (TM), 17transwomen (TW) were included. At baseline, TM were younger than TW (22.7±5.3 vs 29.7±9.7years,p=0.008), had higher HDLc (1.36 vs 1.18mmol/L,p=0.01), and higher smoking prevalence (70.6% vs 11.8%, p=0.001). Both groups had a CAC score and carotid plaque volume of zero. During follow-up, TW showed a modest increase in carotid plaque volume and CAC scores, whereas TM showed no change. Progression of coronary plaque volume was observed in 70% of TW compared with 22% of TM, indicating a clear, although non-significant, trend toward greater atherosclerotic development in TW.

Conclusion: This pilot study suggests a more pronounced progression of atherosclerosis in TW undergoing GAHT, detectable particularly through CCTA. These findings support refined CV monitoring and highlight the need for larger, long-term studies to guide preventive strategies in transgender populations.

Keywords: 3-dimensional supra-aortic trunk ultrasonography; atherosclerosis; cardiovascular risk; coronary computed tomography angiography; gender-affirming hormone therapy; transgender.

Plain language summary

Our study examines how advanced imaging tools can better detect early cardiovascular risk in transgender individuals on gender-affirming hormone therapy, highlighting a tendency toward greater atherosclerosis progression in transgender women. Traditional tools like coronary calcium scoring may underestimate risk in this generally young transgender population, making more sensitive and innovative imaging techniques such as coronary CT angiography and 3D vascular ultrasound particularly valuable.Improving cardiovascular monitoring in transgender people could help develop more effective prevention strategies and enhance long-term heart health.

PubMed Disclaimer

Comment in

LinkOut - more resources